Nuclear Medicine Radioisotope Market to Register Strong Growth at CAGR 12.3% by 2023 | Global Key Players (Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan, Curium, Digirad, GE)

Marketprognosis.com Publish a New Market Research Report On “Global Nuclear Medicine Radioisotope Market 2018 - 2023” which contains global key player’s survey information and forecast to 2023.

Overview of the Global Nuclear Medicine Radioisotope Market:

The report spread across 116 pages is an overview of the Global Nuclear Medicine Radioisotope Market. These report study based on the Nuclear Medicine Radioisotope Market. It is a complete overview of the market, covering various aspects prevailing market landscape. It accumulates comprehensive information and research methodologies.

The Global Nuclear Medicine Radioisotope Market was valued at USD 13.9 Billion in 2017, and is expected to register a CAGR of 12.3% during the forecast period of 2018-2023. North America accounted for the largest share of approximately 40% of the global market, in 2017, whereas, Asia-Pacific is anticipated to register the highest CAGR over the forecast period.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/17164 .

The field of nuclear medicine is dominated by the applications related to positron emission tomography (PET) and single-photon emission computerized tomography (SPECT). The growing interest of PET technology in cardiac and neurological disorders is expected to fuel the market’s growth. More than 60% of SPECT procedures are performed in cardiology. In addition, orthopedics, oncology, and infection imaging are emerging as areas that can benefit from the same. Applications have been further increasing, through the inclusion of advancements in computed tomography (CT), making nuclear medicine the right choice for disease diagnosis. In addition, factors, such as rising incidences of cardiac and cancer cases, along with the rising awareness among the public, drive the nuclear medicine market.

One of the major hindrance for the nuclear medicine radioisotope market is the high capital investments required for the generation of radionuclide. Cyclotron initial investment is very high, which is followed by renovation and installation. Further, annual operating costs are involved. With high investment, the cost of imaging and treatment becomes a factor of high expenditure, especially in developing markets. These factors, and unclear regulatory guidelines, varied reimbursement policies, and short half-life of radiopharmaceuticals restrict the growth of the market studied.

Purchase this report online with 116 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/17164 .

The global nuclear medicine radioisotope market has been segmented by type of radioisotope, application in different indications, and geography. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.

North America dominated the nuclear medicine radioisotope market, with a share of 40%, in 2017. The factors, such as well-established healthcare facilities, growing geriatric population, rising awareness among people for nuclear medicine treatments and diagnosis, contribute to the growth of the regional market. Moreover, Asia-Pacific is estimated to register the highest CAGR during the forecast period.

Major Key Players:

1 Agfa-Gevaert Group

2 Braco

3 Cardiarc Ltd

4 Cardinal Health Inc.

5 CMR Naviscan (Gamma Medica Inc.)

6 Curium

7 Digirad Corporation

8 GE Healthcare and More………….

Any Query? Ask to our Expert @ https://marketprognosis.com/sample-request/17164 .

What Information does this report contain?

1 A detailed analysis of regulatory trends, drivers, industry pitfalls, challenges and growth opportunities for participants

2 Which are the leading market products, applications & regions and how will they perform by 2023?

3 What are the technologies & innovation trends, how will they evolve by 2023?

4 Which companies lead the industry, how are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Nuclear Medicine Radioisotope Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.
Thane – 421501
India.

sales@marketprognosis.com
+1 973 241 5193
https://www.marketprognosis.com

This release was published on openPR.